Recover Investment Losses: Class Action Initiated Against Capricor Therapeutics, Inc. (CAPR)
Levi & Korsinsky, LLP announced a class action lawsuit against Capricor Therapeutics on behalf of investors who purchased securities between December 17, 2025, and July 29, 2026. The complaint alleges Capricor made false statements regarding changes to the statistical analysis plan for its lead candidate Deramiocel and that the FDA had not agreed to those changes prior to BLA resubmission.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.